{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:38:57Z","timestamp":1758591537389,"version":"3.44.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiolog\u00eda"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.rx.2020.04.009","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T02:04:09Z","timestamp":1591668249000},"page":"417-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cribado en pacientes con riesgo incrementado de c\u00e1ncer de mama (parte 2). \u00bfD\u00f3nde estamos? Controversias actuales del cribado con resonancia magn\u00e9tica"],"prefix":"10.1016","volume":"62","author":[{"given":"S.","family":"Alonso Roca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Delgado Laguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Arantzeta Lexarreta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cajal Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"L\u00f3pez Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rx.2020.04.009_bib0410","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"N Eng J Med."},{"key":"10.1016\/j.rx.2020.04.009_bib0415","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA."},{"key":"10.1016\/j.rx.2020.04.009_bib0420","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","article-title":"Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)","volume":"365","author":"Leach","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.rx.2020.04.009_bib0425","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1148\/radiol.2423051965","article-title":"Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results","volume":"242","author":"Sardanelli","year":"2007","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0430","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","article-title":"Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer","volume":"23","author":"Kuhl","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0435","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/cncr.20971","article-title":"Screening women at high risk for breast cancer with mammography and magnetic resonance imaging","volume":"103","author":"Lehman","year":"2005","journal-title":"Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0440","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.breast.2007.01.006","article-title":"Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series","volume":"16","author":"Hagen","year":"2007","journal-title":"The breast."},{"key":"10.1016\/j.rx.2020.04.009_bib0445","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1158\/1078-0432.CCR-07-1270","article-title":"Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer","volume":"13","author":"Riedl","year":"2007","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.rx.2020.04.009_bib0450","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","article-title":"Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer","volume":"148","author":"Warner","year":"2008","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.rx.2020.04.009_bib0455","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1200\/JCO.2009.24.4277","article-title":"Multimodality screening of high-risk women: a prospective cohort study","volume":"27","author":"Weinstein","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0460","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","article-title":"Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial","volume":"28","author":"Kuhl","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0465","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/RLI.0b013e3181f3fcdf","article-title":"Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results","volume":"46","author":"Sardanelli","year":"2011","journal-title":"Invest Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0470","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","article-title":"Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density","volume":"33","author":"Riedl","year":"2015","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0475","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clbc.2015.01.006","article-title":"Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging","volume":"15","author":"Pederson","year":"2015","journal-title":"Clin Breast Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0480","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1148\/radiol.2017170458","article-title":"Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk","volume":"286","author":"Vreemann","year":"2018","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0485","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10549-019-05152-9","article-title":"High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer","volume":"175","author":"Bick","year":"2019","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.04.009_bib0490","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast Cancer Screening in Women at\u00a0Higher-Than-Average Risk: Recommendations From the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J Am Coll Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0495","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jamaoncol.2017.1256","article-title":"Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy","volume":"3","author":"Cho","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0500","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1148\/radiol.13130307","article-title":"Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening","volume":"269","author":"Haas","year":"2013","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0505","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.rx.2011.11.013","article-title":"Breast cancer screening in high risk populations","volume":"54","author":"Alonso Roca","year":"2012","journal-title":"Radiologia."},{"key":"10.1016\/j.rx.2020.04.009_bib0510","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.rx.2020.04.009_bib0515","first-page":"297","article-title":"Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening","volume":"68","author":"Smith","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.rx.2020.04.009_bib0520","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"46","author":"Sardanelli","year":"2010","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0525","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","article-title":"Breast MRI: guidelines from the European Society of Breast Imaging","volume":"18","author":"Mann","year":"2008","journal-title":"Eur Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0530","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s00330-016-4612-z","volume":"27","author":"Sardanelli","year":"2017","journal-title":"Eur Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0535","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","article-title":"Breast MRI: EUSOBI recommendations for women's information","volume":"25","author":"Mann","year":"2015","journal-title":"Eur Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0540","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","article-title":"Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer","volume":"7","author":"Lee","year":"2010","journal-title":"J Am Coll Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0545","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacr.2012.09.036","article-title":"ACR Appropriateness Criteria Breast Cancer Screening","volume":"10","author":"Mainiero","year":"2013","journal-title":"J Am Coll Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0550","unstructured":"Gu\u00eda NCCN: National Comprehensive Cancer Network (Estados Unidos) [acceso el 19 de septiembre de 2019]. Disponible en: https:\/\/www2.tri-kobe.org\/nccn\/guideline\/gynecological\/english\/genetic_familial.pdf. https:\/\/www2.tri-kobe.org\/nccn\/guideline\/breast\/english\/breast-screening.pdf."},{"key":"10.1016\/j.rx.2020.04.009_bib0555","first-page":"184","article-title":"Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening","volume":"69","author":"Smith","year":"2019","journal-title":"CA Cancer J Clin."},{"issue":"suppl 5","key":"10.1016\/j.rx.2020.04.009_bib0560","doi-asserted-by":"crossref","first-page":"v103","DOI":"10.1093\/annonc\/mdw327","article-title":"Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening","volume":"27","author":"Paluch-Shimon","year":"2016","journal-title":"Ann Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0565","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cncr.26424","article-title":"Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis","volume":"118","author":"Lowry","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0570","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ijc.28014","article-title":"Optimal age to start preventive measures in women with BRCA1\/2 mutations or high familial breast cancer risk","volume":"133","author":"Tilanus-Linthorst","year":"2013","journal-title":"Int J Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0575","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/cncr.27864","article-title":"Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers","volume":"119","author":"Cott Chubiz","year":"2013","journal-title":"Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0580","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000375390","article-title":"Intensified surveillance for early detection of breast cancer in high-risk patients","volume":"10","author":"Bick","year":"2015","journal-title":"Breast Care (Basel)."},{"key":"10.1016\/j.rx.2020.04.009_bib0585","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","article-title":"SEOM clinical guidelines in Hereditary Breast and ovarian cancer","volume":"17","author":"Llort","year":"2015","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0590","unstructured":"Gu\u00eda NICE: The National Institute for Health and Care Excellence (Reino Unido). [acceso 23 de septiembre de 2019]. Disponible en: https:\/\/www.nice.org.uk\/guidance\/cg164\/chapter\/Recommendations#surveillance-and-strategies-for-early-detection-of-breast-cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0595","unstructured":"Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Magnetic resonance Imaging Screening of women at High Risk for Breast cancer. Version: 3 ID: 15-11 Jan 2018 [acceso 15 de Ene de 2020]. Disponible en:. htps:\/\/www.cancercareontario.ca\/en\/guidelines-advice\/types-of-cancer\/2051."},{"key":"10.1016\/j.rx.2020.04.009_bib0600","unstructured":"Gu\u00eda NHS: Breast Screening Programme (NHSBSP) guidance and recommendations [acceso 19 de enero de 2020]. Disponible en:.https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/767843\/Guidelines_on_organising_the_surveillance_of_women_at_higher_risk_of_developing_breast_cancer.pdf."},{"key":"10.1016\/j.rx.2020.04.009_bib0605","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","article-title":"BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study","volume":"28","author":"Rijnsburger","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0610","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1200\/JCO.2012.46.5732","article-title":"Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma","volume":"31","author":"Ng","year":"2013","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0615","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s11547-016-0667-9","article-title":"Mammography and MRI for screening women who underwent chest radiation therapy (lymphoma survivors): recommendations for surveillance from the Italian College of Breast Radiologists by SIRM","volume":"121","author":"Mariscotti","year":"2016","journal-title":"Radiol Med."},{"key":"10.1016\/j.rx.2020.04.009_bib0620","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.10100991","article-title":"Screening breast MR imaging in women with a history of chest irradiation","volume":"259","author":"Sung","year":"2011","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0625","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.28747","article-title":"Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging","volume":"120","author":"Tieu","year":"2014","journal-title":"Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0630","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cncr.27771","article-title":"Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy","volume":"119","author":"Freitas","year":"2013","journal-title":"Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0635","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","article-title":"Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging","volume":"9","author":"Warner","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0640","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/1055-9965.EPI-11-1196","article-title":"et al. Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined","volume":"21","author":"Heijnsdijk","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/j.rx.2020.04.009_bib0645","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1148\/radiol.2017161218","article-title":"Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography","volume":"285","author":"van Zelst","year":"2017","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0650","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2017.07.055","article-title":"Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis","volume":"85","author":"Phi","year":"2017","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0655","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejrad.2018.07.026","article-title":"Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System","volume":"106","author":"Marino","year":"2018","journal-title":"Eur J Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0660","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10549-014-2888-8","article-title":"Should we screen BRCA1 mutation carriers only with MRI?. A multicenter study","volume":"144","author":"Obdeijn","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.rx.2020.04.009_bib0665","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10549-017-4198-4","article-title":"Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers","volume":"163","author":"Krammer","year":"2017","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.04.009_bib0670","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejca.2016.05.012","article-title":"Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models","volume":"63","author":"Obdeijn","year":"2016","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0675","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10549-016-3912-y","article-title":"Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study","volume":"158","author":"Narayan","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.04.009_bib0680","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1148\/radiol.2017161103","article-title":"Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging","volume":"285","author":"Lo","year":"2017","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0685","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2013.52.8331","article-title":"Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program","volume":"32","author":"Chiarelli","year":"2014","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0690","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/bjc.2016.32","article-title":"Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis","volume":"114","author":"Phi","year":"2016","journal-title":"Br J Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0695","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1158\/1078-0432.CCR-18-0200","article-title":"Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers","volume":"25","author":"Guindalini","year":"2018","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.rx.2020.04.009_bib0700","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1158\/1078-0432.CCR-18-3145","article-title":"More Is More: Semiannual Breast MRI Screening in BRCA1 Mutation Carriers","volume":"25","author":"Kuhl","year":"2019","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.rx.2020.04.009_bib0705","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00404-013-3022-6","article-title":"Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers","volume":"289","author":"Bosse","year":"2014","journal-title":"Arch Gynecol Obstet."},{"key":"10.1016\/j.rx.2020.04.009_bib0710","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ijc.31794","article-title":"Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?","volume":"144","author":"Cortesi","year":"2019","journal-title":"Int J Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0715","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2214\/AJR.13.11816","article-title":"Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study","volume":"203","author":"Trimboli","year":"2014","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.rx.2020.04.009_bib0720","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jmri.21854","article-title":"Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T","volume":"30","author":"Tsushima","year":"2009","journal-title":"J Magn Reson Imaging."},{"key":"10.1016\/j.rx.2020.04.009_bib0725","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.mri.2015.06.002","article-title":"Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): An accurate and alternative strategy for detecting and differentiating breast lesions","volume":"33","author":"Telegrafo","year":"2015","journal-title":"Magn Reson Imaging."},{"key":"10.1016\/j.rx.2020.04.009_bib0730","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2214\/AJR.15.15873","article-title":"Performance of DWI as a Rapid Unenhanced Technique for Detecting Mammographically Occult Breast Cancer in Elevated-Risk Women With Dense Breasts","volume":"207","author":"McDonald","year":"2016","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.rx.2020.04.009_bib0735","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jmri.25131","article-title":"Evaluating the diagnostic sensitivity of computed diffusion-weighted MR imaging in the detection of breast cancer","volume":"44","author":"O\u2019Flynn","year":"2016","journal-title":"J Magn Reson Imaging."},{"key":"10.1016\/j.rx.2020.04.009_bib0740","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/RLI.0000000000000433","article-title":"Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging","volume":"53","author":"Baltzer","year":"2018","journal-title":"Invest Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0745","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.crad.2016.10.020","article-title":"False-negative MRI breast screening in high-risk women","volume":"72","author":"Maxwell","year":"2017","journal-title":"Clin Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0750","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10549-014-2931-9","article-title":"MRI breast screening in high-risk women: cancer detection and survival analysis","volume":"145","author":"Evans","year":"2014","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.04.009_bib0755","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1148\/radiol.2016151419","article-title":"Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results","volume":"280","author":"Sung","year":"2016","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0760","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1002\/cncr.25971","article-title":"Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer","volume":"117","author":"Le-Petross","year":"2011","journal-title":"Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0765","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40064-015-0793-1","article-title":"Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules","volume":"4","author":"Othman","year":"2015","journal-title":"Springerplus."},{"key":"10.1016\/j.rx.2020.04.009_bib0770","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jnci\/djt203","article-title":"Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging","volume":"105","author":"Saadatmand","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.rx.2020.04.009_bib0775","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/bjc.2012.204","article-title":"Long-term results of screening with magnetic resonance imaging in women with BRCA mutations","volume":"107","author":"Passaperuma","year":"2012","journal-title":"Br J Cancer."},{"key":"10.1016\/j.rx.2020.04.009_bib0780","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1200\/JCO.2014.56.6232","article-title":"Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age \u2265 50 years: evidence from an individual patient data meta-analysis","volume":"33","author":"Phi","year":"2015","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.04.009_bib0785","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-016-3805-0","article-title":"An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers","volume":"157","author":"Madorsky-Feldman","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.04.009_bib0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejrad.2018.04.028","article-title":"MRI-based quantification of residual fibroglandular tissue of the breast after conservative mastectomies","volume":"104","author":"Woitek","year":"2018","journal-title":"Eur J Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0795","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jamasurg.2017.3422","article-title":"Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study","volume":"153","author":"Jakub","year":"2018","journal-title":"JAMA Surg."},{"key":"10.1016\/j.rx.2020.04.009_bib0800","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1148\/radiol.2019190971","article-title":"Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes","volume":"293","author":"Gao","year":"2019","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.04.009_bib0805","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00330-018-5721-7","article-title":"Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?","volume":"29","author":"Taron","year":"2019","journal-title":"Eur Radiol."},{"key":"10.1016\/j.rx.2020.04.009_bib0810","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejrad.2017.10.001","article-title":"Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study","volume":"97","author":"Jochelson","year":"2017","journal-title":"Eur J Radiol."}],"container-title":["Radiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833820300680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833820300680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:46:14Z","timestamp":1758501974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033833820300680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0033833820300680"],"URL":"https:\/\/doi.org\/10.1016\/j.rx.2020.04.009","relation":{},"ISSN":["0033-8338"],"issn-type":[{"type":"print","value":"0033-8338"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cribado en pacientes con riesgo incrementado de c\u00e1ncer de mama (parte 2). \u00bfD\u00f3nde estamos? Controversias actuales del cribado con resonancia magn\u00e9tica","name":"articletitle","label":"Article Title"},{"value":"Radiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rx.2020.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SERAM. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}